A First Examination Report from the Indian Patent Office should be treated as an objection-by-objection prosecution record. The response may need legal and technical arguments, claim or specification amendments, formal corrections, supporting documents, and a plan for hearing if objections remain unresolved.
An FER response should convert each objection into a defined prosecution task. Under the current Patent Rules, the period for putting an application in order for grant under Section 21 is six months from issuance of the first statement of objections, with a further three-month extension available through Form 4 if requested before expiry of the original period. The particular FER and current official record should still be checked before filing.
The First Examination Report can combine substantive patentability issues with formal and procedural requirements. A useful response therefore begins by separating the objections rather than drafting one general narrative. Novelty and inventive step require prior-art analysis. Section 3 objections require attention to the statutory exclusion actually invoked. Clarity, support and sufficiency issues require careful review of the specification and claims. Formal objections may require corrected forms, documents, statements or drawing changes. Different objections often need different forms of evidence and different drafting techniques.
| FER issue | Primary response task | Key drafting question |
|---|---|---|
| Novelty / anticipation | Map each claimed feature against the cited document | Does one cited disclosure contain every required claim feature in the claimed combination? |
| Inventive step | Test the examiner's combination and reasoning | What technical distinction and effect support non-obviousness over the cited art? |
| Section 3 exclusion | Address the specific statutory exclusion | Does the claim, properly construed, fall within the invoked excluded category? |
| Clarity, support or sufficiency | Clarify language without introducing unsupported subject matter | Can the objection be answered from the original disclosure or is a supported amendment needed? |
| Formal / procedural requirement | Correct the identified filing deficiency | Which form, statement, document, signature, data or specification change is required? |
For a novelty objection, list the elements of each affected independent claim and identify the exact passages, figures or claims in the cited reference relied on by the examiner. Then test whether a single disclosure actually contains the claimed combination. A precise feature-by-feature distinction is usually more useful than a general assertion that the invention is different.
An inventive-step response should identify what is already known, what differentiates the claim, the technical consequence of that distinction, and why the cited documents would not lead the skilled person to the claimed solution in the asserted manner. Where multiple documents are combined, the response should test both the factual compatibility of the teachings and the reasoning used to combine them.
Section 3 contains different exclusions with different legal and technical questions. A response to a computer-related invention under Section 3(k) should not be written like a pharmaceutical response involving Section 3(d). The FER should be mapped to the exact statutory language, the current examination guidance where applicable, and the technical disclosure in the application.
A proposed amendment should solve a defined objection without creating another problem. Before filing, record where each new limitation or wording change is supported in the specification, claims or drawings as originally filed. The response should also check whether the amended claims remain internally consistent with the description and whether consequential edits are required elsewhere.
Formal objections should be handled as a checklist. If the FER requests a document, corrected statement, amendment, clarification or other compliance item, identify the exact filing component that will satisfy the requirement and verify that it is included with the response. Leaving a procedural item unresolved can delay allowance even where the substantive claims are otherwise defensible.
Section 14 requires the Controller to communicate the gist of adverse objections and provides an opportunity to be heard where requested within the prescribed framework. Rule 28 and Rule 28A further address contested objections and hearing procedure in relevant examination situations. If the written response may not fully resolve a substantive dispute, the applicant should consider the hearing pathway early rather than treating it as an afterthought.
| Objection family | Evidence to review | Possible response approach | Residual risk to test |
|---|---|---|---|
| Novelty | Cited document, priority/publication data, claim chart | Argument, supported claim distinction, or amendment | Whether another citation still anticipates the amended claim |
| Inventive step | Cited combination, common general knowledge, technical effect | Challenge combination/reasoning, explain technical advance, or amend | Whether the amendment merely shifts the same obviousness issue |
| Section 3(k) | Claim substance, technical implementation, current CRI guidance | Clarify technical contribution and claim character where support exists | Whether wording still reads as excluded subject matter |
| Section 3(d) | Claimed substance, known substance, asserted property/effect and evidence | Address the statutory test and supporting technical record | Whether the record supports the claimed distinction under current law |
| Clarity / support / sufficiency | Original specification, examples, drawings, dependent claims | Explanation and/or supported amendment | Unsupported added limitation or unresolved ambiguity |
| Formal compliance | FER checklist, forms, statements and filed documents | Correct and file the required item | Incomplete correction or mismatch across documents |
Rule 24B currently provides six months from issuance of the first statement of objections to put the application in order for grant under Section 21. The period may be extended by three months through Form 4 if the extension request and prescribed fee are filed before the original six-month period expires. Section 21 states that the application is deemed abandoned if the statutory requirements are not complied with within the prescribed period.
| Stage | Current official rule position | Production implication |
|---|---|---|
| FER / first statement of objections issued | Starts the Section 21 compliance period | Record the issue date and calculate the deadline immediately |
| Ordinary compliance period | Six months under Rule 24B(5) | Do not postpone substantive analysis until the end of the period |
| Extension | Up to three months under Rule 24B(6), requested in Form 4 before expiry | Decide extension needs early and verify the current fee and filing mechanics |
| Failure to comply | Section 21 provides for deemed abandonment | Deadline control is part of the legal response, not an administrative afterthought |
A novelty response is strongest when it identifies a concrete missing limitation or relationship. The response should compare the actual claim language with the specific cited passage rather than rely only on an invention-level description. If amendment is considered, the applicant should distinguish between adding a limitation that is genuinely supported and merely importing implementation detail that may unnecessarily narrow future enforcement value.
Where the FER relies on more than one reference, the response should test why the examiner says those teachings would be combined and whether the proposed combination preserves the technical context of the references. The drafting should identify the claimed technical relationship, the effect produced by that relationship, and the reason the cited material does not make the claimed arrangement an evident choice. Unsupported statements that the invention is "non-obvious" add little without this analytical link.
For computer-related inventions, the page and response should use current official guidance rather than an outdated rule of thumb that all software-related claims are excluded. IP India's published CRI materials discuss the wording "computer programme per se" and the examination of computer-related inventions. The response should focus on the actual claim, disclosed technical implementation, and the statutory exclusion cited in the FER. Related applicants should also review the site's Software Patents in India page for filing and claim-structure context.
Pharmaceutical and chemistry applications can involve different Section 3 issues from software, diagnostics, methods of treatment or other technologies. The FER response should therefore identify the exact exclusion, the claim type, the factual premise relied on by the examiner and the evidence already present in the specification. Where additional evidence may be legally usable, the role and limits of that evidence should be evaluated before submission.
A well-designed amendment has a defined purpose. It may distinguish a cited reference, remove ambiguity, align terminology, correct dependency, or clarify a technical relationship. Before filing, prepare an amendment-basis table showing the proposed wording, the location of support in the original disclosure, the FER objection being addressed and the expected effect on claim scope. This creates an internal check against accidental narrowing and unsupported language.
Section 14 provides for communication of adverse examiner findings and an opportunity of hearing where required. Rule 28 provides a hearing procedure in anticipation cases, including written submissions after hearing, and Rule 28A applies the Rule 28 procedure where the applicant contests objections communicated under Section 14. The applicant should therefore preserve a clear written record of disputed issues and proposed amendments in anticipation of a possible hearing rather than rewriting the case only after a hearing notice arrives.
An Indian prosecution response should be coordinated with the international patent family without assuming that an argument accepted elsewhere will automatically resolve the Indian objection. PCT search results, foreign examination reports and amendments can reveal useful distinctions, but the India response must satisfy the Patents Act, Patent Rules and current Indian Patent Office practice. For PCT cases, the applicant should also consider how the national-phase claim set relates to earlier Article 19 or Article 34 amendments and any Written Opinion findings.
Continue through the global office action response guide, India PCT national phase guide, PCT guide, national phase hub, software patents in India, filing strategy and where-to-file guide.
Evidence note: The Patents Act, current Patent Rules and applicable official Indian Patent Office communications control over generalized prosecution summaries. Current official material should be checked again before filing because examination guidance, forms, fees and procedures can change.
The cited documents, statutory objection, original disclosure, pending claims and wider patent family should be reviewed together before amendments or arguments are committed to the Indian prosecution record.
rd (at) patentbusinesslawyer (dot) com
For original-disclosure, support and fallback-position planning, continue to India Patent Drafting.
